MyAverix Finance
SHG · Healthcare
Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329)
Drug Manufacturers - Specialty & Generic
Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) is listed on SHG in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-28, reported market cap is $33.90B, P/E ratio is 9.47, net margin is 66.7%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 600329
Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) — FAQ
What is Tianjin Zhongxin Pharmaceutical Group Corp Ltd's market cap?
Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) has a reported market cap of $33.90B (data as of 2026-03-28).
What is 600329's P/E ratio?
The price-to-earnings (P/E) ratio for Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) is 9.47 (data as of 2026-03-28).
Does Tianjin Zhongxin Pharmaceutical Group Corp Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329). Check the MyAverix Finance app for the latest dividend data.
What sector is Tianjin Zhongxin Pharmaceutical Group Corp Ltd in?
Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 600329 listed on?
600329 is listed on SHG.
What is Tianjin Zhongxin Pharmaceutical Group Corp Ltd's net margin?
Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) reports a net margin of 66.7% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.